Leqembi: The brain drug (Alzheimer’s) that damages the brain

2023-06-07 17:53:46

Lecanemab It is a drug indicated for the treatment of Alzheimer disease. It is marketed under the name This group.

It is one of the treatments that has generated the most expectation in recent decades… but it turns out that DAMAGE THE BRAIN OF THE SICK (the last thing you need, RIGHT?).

Specific, as reported by the newspaper El Paísnothing suspected of being critical of pharmaceuticals:

«The most promising drug against Alzheimer’s in recent decades reduces the size of the brain of patients without knowing why or what effects it may have in the long term.

One of the first scientists to sound the alarm was the neurologist at the University of Melbourne (Australia) Scott Ayton in a study published in the magazine Neurology.

The “wonders” of the drug (as almost always “science» turned into marketing) counted by their manufacturers:

• Lecanemab stops 27% cognitive impairment caused by the disease.
• A phase III clinical study has shown that lecanemab, developed by biopharmaceutical companies Biogen y Eisaireduces the progression of Alzheimer’s.
• It is approved by the United States Food and Drug Administration (FDA).

But the aforementioned scientist has made a call to continue investigating his dangerous side effectssince the pharmaceutical companies involved in the development of lecanemab have refused to provide more data.

And it is not the first case of pharmaceutical failure when it comes to this delicate disease, Alzheimer’s. A couple of years ago the FDA approved another Alzheimer’s drug called aducanumabwhich turned out to be a real fiasco and led to the resignation of three of the experts who examined it.

And who was behind the failed aducanumab? Well, the same North American pharmaceutical that is now promoting the “brain shrinking” drug.

In May 2023, Biogen announced that it was discontinuing its marketing of aducanumab as it resulted in a clinical failure and commercial. The drug can cause side effects such as inflammation and cerebral hemorrhages.

Conclusion: We cannot trust the goings-on of the pharmaceutical industry. There are too many interests at stake and their greed is insatiable.

A medium and long-term advice:

To prevent Alzheimer’s fighting cognitive declinenothing better than betting on flavonoids, some antioxidants incredibly beneficial for brain health. Y to know what foods contain them… you just have to look at the colors of the fruits and vegetables!

If you or a family member or acquaintance has suffered damage Contact us to review your case.

Related